ImmunityBio,
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmunityBio, and other ETFs, options, and stocks.About IBRX
ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases.
CEORichard Adcock
CEORichard Adcock
Employees680
Employees680
HeadquartersSan Diego, California
HeadquartersSan Diego, California
Founded2014
Founded2014
Employees680
Employees680
IBRX Key Statistics
Market cap5.25B
Market cap5.25B
Price-Earnings ratio-9.39
Price-Earnings ratio-9.39
Dividend yield—
Dividend yield—
Average volume23.06M
Average volume23.06M
High today$5.55
High today$5.55
Low today$4.22
Low today$4.22
Open price$4.72
Open price$4.72
Volume144.95M
Volume144.95M
52 Week high$5.55
52 Week high$5.55
52 Week low$1.83
52 Week low$1.83
Stock Snapshot
With a market cap of 5.25B, ImmunityBio,(IBRX) trades at $5.34. The stock has a price-to-earnings ratio of -9.39.
During the trading session on 2026-01-16, ImmunityBio,(IBRX) shares reached a daily high of $5.55 and a low of $4.22. At a current price of $5.34, the stock is +26.4% higher than the low and still -3.9% under the high.
Trading activity shows a volume of 144.95M, compared to an average daily volume of 23.06M.
Over the past 52 weeks, ImmunityBio,(IBRX) stock has traded between a high of $5.55 and a low of $1.83.
Over the past 52 weeks, ImmunityBio,(IBRX) stock has traded between a high of $5.55 and a low of $1.83.
People also own
Based on the portfolios of people who own IBRX. This list is generated using Robinhood data, and it’s not a recommendation.